LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | Dovitinib | 3.33 | uM | LJP5 | 72 | hr | 1657 | 2475 | 5505 | 0.4495 | 0.2124 |
BT-20 | Enzastaurin | 3.33 | uM | LJP5 | 72 | hr | 1657 | 6589 | 5505 | 1.1969 | 1.2817 |
BT-20 | Erlotinib | 3.33 | uM | LJP5 | 72 | hr | 1657 | 4827 | 5505 | 0.8768 | 0.8237 |
BT-20 | Foretinib | 3.33 | uM | LJP5 | 72 | hr | 1657 | 1624 | 5505 | 0.2950 | -0.0087 |
Hs 578T | SU11274 | 0.37 | uM | LJP5 | 72 | hr | 929 | 3089 | 3228 | 0.9569 | 0.9395 |
Hs 578T | Fedratinib | 0.37 | uM | LJP5 | 72 | hr | 929 | 2959 | 3228 | 0.9169 | 0.8833 |
Hs 578T | Tozasertib | 0.37 | uM | LJP5 | 72 | hr | 929 | 1386 | 3228 | 0.4294 | 0.1987 |
BT-20 | Geldanamycin | 3.33 | uM | LJP5 | 72 | hr | 1657 | 1735 | 5505 | 0.3153 | 0.0203 |
BT-20 | WH-4-025 | 0.37 | uM | LJP5 | 72 | hr | 1657 | 3593 | 5505 | 0.6527 | 0.5031 |
BT-20 | GSK1059615 | 3.33 | uM | LJP5 | 72 | hr | 1657 | 968 | 5505 | 0.1758 | -0.1793 |
BT-20 | SB590885 | 0.04 | uM | LJP5 | 72 | hr | 1657 | 5376 | 5505 | 0.9765 | 0.9663 |
BT-20 | Sigma A6730 | 0.04 | uM | LJP5 | 72 | hr | 1657 | 4910 | 5505 | 0.8918 | 0.8452 |
BT-20 | XMD16-144 | 0.37 | uM | LJP5 | 72 | hr | 1657 | 2144 | 5505 | 0.3894 | 0.1264 |
BT-20 | GSK 690693 | 3.33 | uM | LJP5 | 72 | hr | 1657 | 3450 | 5505 | 0.6266 | 0.4658 |
BT-20 | Brivanib | 0.37 | uM | LJP5 | 72 | hr | 1657 | 5313 | 5505 | 0.9651 | 0.9501 |
BT-20 | HG-5-113-01 | 3.33 | uM | LJP5 | 72 | hr | 1657 | 2727 | 5505 | 0.4954 | 0.2781 |
BT-20 | Buparlisib | 0.37 | uM | LJP5 | 72 | hr | 1657 | 3669 | 5505 | 0.6665 | 0.5229 |
BT-20 | NU7441 | 3.33 | uM | LJP5 | 72 | hr | 1657 | 5366 | 5505 | 0.9747 | 0.9638 |
BT-20 | BX-912 | 0.37 | uM | LJP5 | 72 | hr | 1657 | 5456 | 5505 | 0.9910 | 0.9872 |
BT-20 | Linsitinib | 0.04 | uM | LJP5 | 72 | hr | 1657 | 4776 | 5505 | 0.8676 | 0.8106 |
BT-20 | NVP-AEW541 | 0.12 | uM | LJP5 | 72 | hr | 1657 | 5821 | 5505 | 1.0573 | 1.0820 |
BT-20 | LDN-193189 | 3.33 | uM | LJP5 | 72 | hr | 1657 | 2144 | 5505 | 0.3895 | 0.1265 |
BT-20 | SB590885 | 0.12 | uM | LJP5 | 72 | hr | 1657 | 5393 | 5505 | 0.9795 | 0.9707 |
BT-20 | Linsitinib | 3.33 | uM | LJP5 | 72 | hr | 1657 | 4834 | 5505 | 0.8781 | 0.8255 |
Hs 578T | AZD8330 | 1.11 | uM | LJP5 | 72 | hr | 929 | 1571 | 3228 | 0.4868 | 0.2793 |